1. MARKETS
  2. SECTOR : DIVERSIFIED CONSUMER SERVICES
  3. INDUSTRY : HEALTHCARE SERVICES
  4. BIORA THERAPEUTICS INC

Biora Therapeutics Inc XNAS: BIOR

Biora Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Download real time

0.22 0.00 (0.00%)

96.31% Fall from 52W High

0 XNAS Volume

XNAS 07 Apr, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Share
Board Meeting
The board meeting for Biora Therapeutics Inc is scheduled for today, for the purpose of Biora Therapeutics Inc Fourth Quarter Earnings Result for 2024 See details

Biora Therapeutics Inc Key Metrics

Select

Market Capitalization

Low in industry
1

Institutional holding current Qtr %

Below industry Median
27.1

Operating Revenue growth TTM %

Market Leader
4,855.6

Net Profit Qtr Growth YoY %

Below industry Median
74.9

Net Profit TTM Growth %

Below industry Median
74.2

Operating Profit Margin Qtr %

Negative Operating Profit Margin Qtr %
-50,709.4

Operating Profit Margin TTM %

Negative Operating Profit Margin TTM %
-6,824.3

Piotroski Score

Low in industry
1

Rel Perf vs Sector quarter%

5

RoA Annual %

Negative RoA Annual %
-292.9
All financials are in USD Million and price data in USD
VIEW MORE

9

S

11

W

0

O

0

T

SWOT Analysis

Check P/E Buy Sell Zone

This stock has negative PE


Biora Therapeutics Inc Live Price Chart

Switch to TradingView
Fetching data ...

Forecaster - Analyst Share Price Target and Estimates

Revenue forecast

Created with Highcharts 7.2.2Dec '22Dec '23Dec '24Dec '25Dec '2602.557.5Actual RevenueAvg. Estimate
Hit

Biora Therapeutics Inc's Revenue was higher than average estimate 1 time in past 1 year

EPS forecast

Current EPS
-78.7
Avg. Estimate
-8.8
Low Estimate
-8.8
High Estimate
-8.8
Current EPS
Avg. Estimate
Hit

EPS is expected to grow by 88.8% in FY24

Consensus Recommendation

1 ANALYST Recommendations
BUY

Created with Highcharts 7.2.21Buy

The consensus recommendation from 1 analyst for Biora Therapeutics Inc is BUY

Forecaster is a Premium Feature
You need to upgrade your subscription plan to access this feature
See what you get

Biora Therapeutics Inc Stock Analysis

Biora Therapeutics Inc stock analysis with key metrics, changes, and trends.

Biora Therapeutics Inc MetricVALUECHANGE %TRENDANALYSIS
Annual Net Profit$124.12 M1.38%negative

Annual Net Profit fell 1.38% in the last year to $124.12 M. Its sector's average net profit growth for the last fiscal year was 3.58%.

Price to Earning Ratio-0.03-negative

Price to Earning Ratio is -0.03, which is negative.

Stock Price$0.22-69.44%negative

Stock Price fell 69.44% and underperformed its sector by 70.54% in the past year.

Quarterly Net profit$18.4 M74.95%positive

Quarterly Net profit rose 74.95% YoY to $18.4 M. Its sector's average net profit growth YoY for the quarter was 37.12%.

Mutual Fund Holding1.59 %0%neutral

Mutual Fund Holding remained the same in the last quarter at 1.59%.

Interest Coverage Ratio-11.68-negative

Interest Coverage Ratio is -11.68, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

Institutional Holding27.06 %0%neutral

Institutional Holding remained the same in the last quarter at 27.06%.

VIEW LESS


Loading data..

Biora Therapeutics Inc - Company Profile

What does Biora Therapeutics Inc do?

Biora Therapeutics Inc is a biotechnology company engaged in developing oral biotherapeutics. Its drug-device combinations could enable new treatment approaches in the delivery of therapeutics in two main areas: Targeted delivery of therapeutics to the site of disease in the gastrointestinal ("GI") tract, which is designed to improve outcomes for patients with Inflammatory Bowel Disease (IBD); and Systemic delivery of biotherapeutics, which are designed to replace injection with needle-free, oral delivery technology.

Biora Therapeutics Inc Management structure

All Gross Remunerations are in USD
Mr. Aditya P. Mohanty
Chief Executive Officer and Director
3.14 M
2023
Gross Remuneration
Year
Mr. Eric d’Esparbes
Chief Financial Officer and Principal Accounting Officer
1.6 M
2023
Gross Remuneration
Year
Mr. Clarke Neumann
Senior Vice President, General Counsel and Secretary
1.53 M
2023
Gross Remuneration
Year

Biora Therapeutics Inc Board of directors

All Gross Remunerations are in USD
Mr. Jeffrey D. Alter
Chairman of the Board
208.11 K
2023
Gross Remuneration
Year
Dr. Brian L. Kotzin, M.D.
Independent Director
185.11 K
2023
Gross Remuneration
Year
Ms. Jill A. Howe
Independent Director
180.11 K
2023
Gross Remuneration
Year
Ms. Lynne Powell
Independent Director
163.11 K
2023
Gross Remuneration
Year
Ms. Surbhi Sarna
Independent Director
28 K
2023
Gross Remuneration
Year
Mr. Aditya P. Mohanty
Chief Executive Officer and Director
-
2023
Gross Remuneration
Year

Biora Therapeutics Inc FAQ

How is Biora Therapeutics Inc today?
Biora Therapeutics Inc today is trading in the red, and is down by 0.00% at 0.22.
Biora Therapeutics Inc is currently trading down 0.00% on an intraday basis. In the past week the stock fell 0.00%. stock has been down 0.00% in the past quarter and fell -69.44% in the past year. You can view this in the overview section.